We develop antibody-based therapies targeting IL1RAP

See our pipeline

Our goal is to treat cancer as well as inflammatory and autoimmune diseases

See our clinical program

Strong results provide support for our development programs

See our company presentation

2025-07-15 Interview with Redeye

2025-07-15 Interview with Redeye

Interview with Damian Marron regarding the acquisition of CAN10 IL1RAP immunology program by Otsuka Pharmaceutical

Watch the interview here

2025-06-11 Redeye Investor Forum, Stockholm

Interim CEO Damian Marron presents at Redeye Investor Forum, Stockholm

Watch the presentation here

2025-06-11 Redeye Investor Forum, Stockholm

2025-03-26 Interview with H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

2025-03-26 Interview with H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

Interview with Interim CEO Damian Marron during the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

Watch the interview here

2025-02-07 Interview with Redeye

Interview with Interim CEO Damian Marron

Watch the interview here

2025-02-07 Interview with Redeye

Press releases

2025-07-17 (R) Cantargia announces preliminary topline efficacy results from the phase 2 TRIFOUR trial of nadunolimab in advanced triple-negative breast cancer (TNBC)

2025-07-16 Cantargia announces publication of clinical data showing benefit of nadunolimab combination therapy in advanced lung cancer

2025-07-15 (R) Cantargia announces the acquisition of its CAN10 IL1RAP immunology program by Otsuka Pharmaceutical

(R) = Regulatory press releases

Analysis

2025-07-18, Redeye analysis of Cantargia

2025-07-15, Redeye analysis of Cantargia

2025-06-11, Redeye analysis of Cantargia

2025-05-12, Redeye analysis of Cantargia

Current corporate presentation

Download the corporate presentation as PDF

Other presentations

2025-06-11, Video, Redeye Investor forum, Stockholm

2025-03-26, Video, H.C. Wainwright Annual Autoimmune & Inflammatory Virtual Conference 2025

2025-02-11, Video, Oppenheimer 35th Annual Healthcare Life Sciences Conference

2025-01-22, Video, Redeye Fight Cancer Event 2025

2024-11-21, Video, BioStock Life Science Summit 2024